APLN and Mental deterioration: These effects were mediated by the brain-derived neurotrophic factor (BDNF)/tropomyosin receptor kinase-B (Trk-B) pathway in the hippocampus [157], which is in line with the activation of this pathway and improved cognitive decline after apelin treatment in rats with cisplatin-induced cognitive dysfunction [159].